Reduction of marrow hematopoietic progenitor and stem cell content is not sufficient for enhanced syngeneic engraftment

Stem Cells

Volumn 18, Issue 2, 2000, Pages 93-101

  Robinson, Simon ^a   Van Os, Ronald ^a   Sheridan, Tara ^a   Mauch, Peter ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NONE   (United States)

Author keywords

Hematopoietic assays; Hematopoietic progenitor cells; Long term engraftment; Syngeneic engraftment

Indexed keywords

CYCLOPHOSPHAMIDE; GLUCOSE 6 PHOSPHATE ISOMERASE; GRANULOCYTE COLONY STIMULATING FACTOR; MYELOABLATIVE AGENT; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW DEPRESSION; CELL COUNT; CELL REGENERATION; CHIMERA; CONTROLLED STUDY; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; ISOGRAFT; LONG TERM CARE; MALE; MOUSE; NONHUMAN;

ANIMALIA;

EID: 0034066776     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.18-2-93     Document Type: Article

References (37)

1. Brecher G, Ansell J, Micklem H et al. Special proliferative sites are not needed for seeding and proliferation of transfused marrow cells in normal syngeneic mice. Proc Natl Acad Sci USA 1982;79;5085-5087.
2. Wu D, Keating A. Hematopoietic stem cells engraft in untreated transplant recipients. Exp Hematol 1993;21:251-256.
3. Stewart F, Crittenden R, Lowry P et al. Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated mice. Blood 1993;81:2566-2571.
4. Tomita Y, Sachs D, Sykes M. Myelosuppressive conditioning is required to achieve engraftment of pluripotent stem cells contained in moderate doses of syngeneic bone marrow. Blood 1994;83:939-948.
5. Neben S, Marcus K, Mauch P. Mobilization of hematopoietic stem and progenitor cell subpopulations from the marrow to the blood of mice following cyclophosphamide and/or granulocyte colony-stimulating factor. Blood 1993;81:1960a.
6. Ploemacher R, van Os R, van Beurden C et al. Murine haemopoietic stem cells with long-term engraftment and marrow repopulating ability are more resistant to gamma-radiation than are spleen colony forming cells. Int J Radiat Biol 1992;61:489-499.
7. Robinson S, Riches A. Haematopoietic stem cell proliferation regulators investigated using an in vitro assay. J Anat 1991;174:153-162.
8. Ploemacher R, van der Sluijs J, Voerman J et al. An in vitro limiting-dilution assay of long-term repopulating hematopoietic stem cells in the mouse. Blood 1989;74:2755-2763.
9. Neben S, Anklesaria P, Greenberger J et al. Quantitation of murine hematopoietic stem cells in vitro by limiting dilution analysis of cobblestone area formation on a cloned stromal cell line. Exp Hematol 1993;21:438-443.
10. Ploemacher R. Cobblestone area forming cell (CAFC) assay. In: Freshney R, Pragnell I, Freshney M, eds. Culture of Hemopoietic Cells. New York: Wiley-Liss Inc., 1994;1-12.
11. van Os R, Dawes D, Mislow J et al. Host conditioning with 5-fluorouracil and kit-ligand to provide for long-term bone marrow engraftment. Blood 1997;89:2376-2383.
12. Fazekas de St. Groth S. The evaluation of limiting dilution assays. J Immunol Methods 1982;49:R11-R23.
13. Roberts A, Metcalf D. Noncycling state of peripheral blood progenitor cells mobilized by granulocyte colony-stimulating factor and other cytokines. Blood 1995;86:1600-1605.
14. Takada Y, Takada A. Proliferation of donor hematopoietic cells in irradiated and unirradiated host mice. Transplantation 1971;12:334-338.
15. Takada A, Takada Y, Ambrus JL. Proliferation of donor spleen and bone-marrow cells in the spleens and bone marrows of unirradiated and irradiated adult mice. Proc Soc Exp Biol Med 1971;136:222-226.
16. Micklem H, Ogden D, Evans E et al. Compartments and cell flows within the mouse haemopoietic system. II. Estimated rates of interchange. Cell Tissue Kinet 1975;8:233-248.
17. Brecher G, Lawce H, Tjio J. Bone marrow transfusions in previously irradiated, hematologically normal syngeneic mice. Proc Soc Exp Biol Med 1981;166:389-393.
18. Down J, Tarbell N, Thames H et al. Syngeneic and allogeneic bone marrow engraftment after total body irradiation: dependence on dose, dose rate, and fractionation. Blood 1991;77:661-669.
19. Down J, Ploemacher R. Transient and permanent engraftment potential of murine hematopoietic subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs. Exp Hematol 1993;21:913-921.
20. Down J, Boudewijn A, Dillingh J et al. Relationships between ablation of distinct haematopoietic cell subsets and the development of donor marrow engraftment following recipient pretreatment with different alkylating drugs. Br J Cancer 1994;70:611-616.
21. Simmons P, Zannettino A, Gronthos S et al. Potential adhesion mechanisms for localisation of haemopoietic progenitors to bone marrow stroma. Leuk Lymphoma 1994;12:353-363.
22. Saxe D, Boggs S, Boggs D. Transplantation of chromosomally marked syngeneic marrow cells into mice not subjected to hematopoietic stem cell depletion. Exp Hematol 1984;12:277-283.
23. Ramshaw HS, Rao SS, Crittenden RB et al. Engraftment of bone marrow cells into normal unprepared hosts: effects of 5-fluorouracil and cell cycle status. Blood 1995;86:924-929.
24. Tavassoli M. The role of conditioning regimens in homing of transplanted hemopoietic cells. Bone Marrow Transplant 1992;10:15-17.
25. Shirota T, Tavassoli M. Cyclophosphamide-induced alterations of bone marrow endothelium: implications in homing of marrow cells after transplantation. Exp Hematol 1991;19:369-373.
26. Bazzoni F, Cassatella M, Rossi F et al. Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin-8. J Exp Med 1991;173:771-774.
27. Elford P, Cooper P. Induction of neutrophil-mediated cartilage degradation by interleukin-8. Arthritis Rheum 1991;34:325-332.
28. Matrisian L. The matrix-degrading metalloproteinases. Bioessays 1992;14:455-463.
29. Goetzl E, Banda M, Leppart D. Matrix metalloproteinases in immunity. J Immunol 1996;156:1-4.
30. Laterveer L, Lindley I, Hamilton M et al. Interleukin-8 induces rapid mobilization of hematopoietic stem cells with radioprotective capacity and long-term myelolymphoid repopulating ability. Blood 1995;85:2269-2275.
31. Laterveer L, Lindley I, Heemskerk D et al. Rapid mobilization of hematopoietic progenitors in rhesus monkeys by a single intravenous injection of interleukin-8. Blood 1996;87:781-788.
32. Liu F, Pourine-Laurent J, Link D. The granulocyte colony-stimulating factor receptor is required for the mobilization of murine hematopoietic progenitors into peripheral blood by cyclophosphamide or interleukin-8 but not Flt-3 ligand. Blood 1997;90:2522-2528.
33. Fibbe W, Pruijt J, Velders G et al. Biology of IL-8-induced stem cell mobilization. Ann NY Acad Sci 1999;872:71-82.
34. Watanabe T, Kawano Y, Kanamaru S et al. Endogenous interleukin-8 (IL-8) surge in granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization. Blood 1999;93:1157-1163.
35. + cells in grafts and time to myeloid and platelet recovery after autologous stem cell transplantation. Exp Hematol 1998;26:10-18.
36. + cells in adhesion molecule expression. Bone Marrow Transplant 1997;19:1175-1181.
37. Craddock CF, Nakamoto B, Andrews RG et al. Antibodies to VLA4 integrin mobilize long-term repopulating cells and augment cytokine-induced mobilization in primates and mice. Blood 1997;90:4779-4788.